X. Garcia-Del-Muro

发表

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

M. Galsky, S. Park, A. Thåström, 2020, The Lancet.

Absence of chromosomal instability in spermatozoa of men affected by testicular cancer.

R. Miró, J. Egozcue, L. Tusell, 1999, Human reproduction.

Results from the INMUNOSUN-SOGUG trial: a prospective phase II study of sunitinib as a second-line therapy in patients with metastatic renal cell carcinoma after immune checkpoint-based combination therapy

B. Mellado, G. De Velasco, E. Esteban, 2022, ESMO open.

Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.

J. Aparicio, P. Maroto, J. Germá-Lluch, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis.

V. Moreno, I. Bover, X. Fabregat, 1998, European journal of cancer.

Prognostic time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) Study.

J. Carles, A. Llombart‐Bosch, R. Andrés, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Etoposide-related acral erythema

F. Cardenal, X. Garcia-Del-Muro, I. Portal, 2004, Cancer Chemotherapy and Pharmacology.

Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent

M. Esteller, E. Guinó, M. Pujana, 2018, Clinical Cancer Research.

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

Xin Huang, Roberto Pili, R. Figlin, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SEOM clinical guidelines for the management of germ cell testicular cancer (2016)

J. Aparicio, I. Durán, E. Gonzalez-Billalabeitia, 2016, Clinical and Translational Oncology.

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.

C. Antonescu, J. Donohue, M. Gönen, 2009, The Lancet. Oncology.

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

N. Mulet-Margalef, X. Garcia-Del-Muro, 2016, OncoTargets and therapy.

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

L. Collette, R. Huddart, C. Bokemeyer, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SEOM clinical guideline for treatment of kidney cancer (2017)

E. Gallardo, J. Pérez-Gracia, E. Grande, 2017, Clinical and Translational Oncology.

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

J. Carles, F. Viñals, S. Indraccolo, 2016, Cell reports.

Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.

J. Maurel, A. de Juan, A. Poveda, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study

N. Mulet-Margalef, J. Martín-Broto, J. López-Martín, 2018, Targeted Oncology.

Extrapyramidal reaction associated with ondansetron.

F. Cardenal, X. Garcia-Del-Muro, P. Ferrer, 1993, European journal of cancer.

Metastatic uveal melanoma: is there a role for conventional chemotherapy? – A single center study based on 58 patients

M. Plana, J. Piulats, F. Pons, 2011, Melanoma research.

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib.

J. Carles, J. Arribas, S. Landolfi, 2018, The oncologist.

Molecular Biomarkers of Prognosis in Advanced Renal Cell Carcinoma Patients Treated With Pazopanib Plus Interferon Alpha (INF-2A) in a Phase I/II Study by the Spanish Oncology Genitourinary Group.

B. Mellado, J. García-Donas, J. Pérez-Gracia, 2022, Clinical genitourinary cancer.

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

N. Mulet-Margalef, X. Garcia-Del-Muro, 2016 .

Sunitinib in the treatment of gastrointestinal stromal tumor: patient selection and perspectives

N. Mulet-Margalef, X. Garcia-Del-Muro, 2016 .

2023 GEIS Guidelines for gastrointestinal stromal tumors

J. Martín-Broto, C. Serrano, J. López-Guerrero, 2023, Therapeutic advances in medical oncology.

Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.

J. Aparicio, P. Maroto, J. Germá-Lluch, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma.

A. Poprach, G. De Velasco, L. Albiges, 2024, The New England journal of medicine.